To test whether vismodegib may directly modulate DR5 expression in hepatocytes, we treated human hepatoma cells (Huh-7) with vismodegib and palmitic acid (600 μM), a known inducer of DR5 [16], and assessed gene expression of the death receptor by real-time PCR. This evidence concerns the gene TNFRSF10B and hepatocellular carcinoma.